CN111967958B - Drug supply management system and method based on blockchain - Google Patents
Drug supply management system and method based on blockchain Download PDFInfo
- Publication number
- CN111967958B CN111967958B CN202010804367.4A CN202010804367A CN111967958B CN 111967958 B CN111967958 B CN 111967958B CN 202010804367 A CN202010804367 A CN 202010804367A CN 111967958 B CN111967958 B CN 111967958B
- Authority
- CN
- China
- Prior art keywords
- information
- medicine
- blockchain
- medical institution
- blockchain network
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 233
- 229940079593 drug Drugs 0.000 title claims abstract description 98
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000003745 diagnosis Methods 0.000 claims abstract description 53
- 238000007726 management method Methods 0.000 claims description 50
- 238000012795 verification Methods 0.000 claims description 25
- 238000010586 diagram Methods 0.000 description 11
- 238000012550 audit Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes
- G06Q40/03—Credit; Loans; Processing thereof
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes
- G06Q40/04—Trading; Exchange, e.g. stocks, commodities, derivatives or currency exchange
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L63/00—Network architectures or network communication protocols for network security
- H04L63/04—Network architectures or network communication protocols for network security for providing a confidential data exchange among entities communicating through data packet networks
- H04L63/0428—Network architectures or network communication protocols for network security for providing a confidential data exchange among entities communicating through data packet networks wherein the data content is protected, e.g. by encrypting or encapsulating the payload
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L67/00—Network arrangements or protocols for supporting network services or applications
- H04L67/01—Protocols
- H04L67/12—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L9/00—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols
- H04L9/32—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system or for message authentication, e.g. authorization, entity authentication, data integrity or data verification, non-repudiation, key authentication or verification of credentials
- H04L9/3247—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system or for message authentication, e.g. authorization, entity authentication, data integrity or data verification, non-repudiation, key authentication or verification of credentials involving digital signatures
Abstract
One or more embodiments of the present specification disclose a blockchain-based drug supply management system and method, including: the medical institution side encrypts and signs the diagnosis information and then uploads the diagnosis information to the blockchain network, and after the diagnosis information is successfully verified by the third party record platform, the medicine supply service is audited, and the auditing result and the sales information in the medicine information are encrypted and signed and then uploaded to the blockchain network; when a patient pays for buying a medicine, the medical institution triggers the third party record platform to verify the diagnosis information, and if successful, the payment information, the order information and the medicine sales state are uploaded to the blockchain network; and the medicine provider packages the uplink information corresponding to the medicine supply business into receivables information and signs the assets corresponding to the medicine purchase. Therefore, the deposit amount to be collected in the period of the sale of the medicine is managed and financing is carried out, the cash flow is increased, the utilization rate of funds is improved in a risk-controllable mode, and the safety of the information flow is ensured.
Description
Technical Field
The present document relates to the field of blockchain technologies, and in particular, to a blockchain-based drug supply management system and method.
Background
Blockchain is a solution for solving the decentralized innovation of the multiparty trust problem by using the distributed ledger wall technology, and is the leading edge technology of the current society.
In the current medicine supply and sales process, if a patient uses medical insurance funds to purchase medicines when purchasing medicines, a long payment process exists for a pharmacy, and the middle part can involve medical insurance bureau, hospital, internet platform and pharmacy. In this case, the pharmacy cannot directly acquire the medical insurance funds, and the medical insurance funds need to be checked for payment and drug information after a billing period, and then the medical insurance funds are paid to the hospital, and the hospital can pay to the pharmacy after checking. The whole payment flow has more participating subjects and longer payment period, and because of the characteristics of difficult tracing and more data participating institutions, the assets which are about to be received but are not actually paid are difficult to be used as accounts receivable by a pharmacy to carry out asset service business, such as financing business, on a financial platform, so that the current medicine supply management efficiency is low and the asset utilization rate is influenced.
Disclosure of Invention
It is an object of one or more embodiments of the present disclosure to provide a drug supply management system and method based on blockchain to improve drug supply management efficiency and thus asset utilization.
To solve the above technical problems, one or more embodiments of the present specification are implemented as follows:
in a first aspect, a blockchain-based drug supply management system is presented, comprising: a medical institution side, a third party record platform, a drug supplier, and a blockchain network; wherein the medical institution side, the third party record platform and the medicine provider are respectively provided with a blockchain node module;
the medical institution side encrypts and signs diagnosis information carrying medicine information and then uploads the diagnosis information to a blockchain network, and sends the diagnosis information to the third party record platform;
the third party record platform compares the received diagnosis information with the diagnosis information stored with the encrypted signature in the blockchain network, and stores the diagnosis information in a corresponding database after comparison and matching;
the third party record platform also carries out auditing on the current medicine supply service, and uploads the auditing result and sales information in the medicine information to a blockchain network after encryption signature;
when a patient pays for buying a medicine, the medical institution triggers the third party record platform to verify the diagnosis information, and uploads payment information, order information and medicine sales state to a blockchain network after the verification is successful;
the medicine provider packages all uplink information corresponding to the medicine supply business to form accounts receivable information and signs the assets corresponding to the medicine purchase; wherein the ownership of the signed asset is attributed to the drug supplier.
In a second aspect, a drug supply management method based on a blockchain is provided, and the drug supply management method is applied to a drug supply management system comprising a medical institution side, a third party recording platform, a drug supplier and a blockchain network; wherein the medical institution side, the third party record platform and the medicine provider are respectively provided with a blockchain node module; the method comprises the following steps:
the medical institution side encrypts and signs diagnosis information carrying medicine information and then uploads the diagnosis information to a blockchain network, and sends the diagnosis information to the third party record platform;
the third party record platform compares the received diagnosis information with the diagnosis information stored with the encrypted signature in the blockchain network, and stores the diagnosis information in a corresponding database after comparison and matching;
the third party record platform carries out auditing on the current medicine supply business, and uploads the auditing result and the sales information encryption signature in the medicine information to a blockchain network;
when a patient pays for buying a medicine, the medical institution triggers the third party record platform to verify the diagnosis information, and uploads payment information, order information and medicine sales state to a blockchain network after the verification is successful;
the medicine provider packages all uplink information corresponding to the medicine supply business to form accounts receivable information, and signs the assets corresponding to the medicine purchase; wherein the ownership of the signed asset is attributed to the drug supplier.
In a third aspect, an electronic device is provided, comprising:
a processor; and
a memory arranged to store computer executable instructions which, when executed, cause the processor to perform the method steps involved in the execution subject of the second aspect.
In a fourth aspect, a computer-readable storage medium is presented, which stores one or more programs, which when executed by an electronic device comprising a plurality of application programs, cause the electronic device to perform the method steps of the execution subject matter of the second aspect.
According to the technical scheme provided by one or more embodiments of the present disclosure, a medicine provider can perform insurance financing on accounts receivable in the period of selling medicine through the system, increase cash flow under the condition that accounts are received immediately but accounts are not actually received, improve the utilization rate of funds in a risk controllable mode, and ensure the safety of information flow.
Drawings
For a clearer description of one or more embodiments of the present description or of the solutions of the prior art, reference will be made below to the accompanying drawings which are used in the description of one or more embodiments or of the prior art, it being apparent that the drawings in the description below are only some of the embodiments described in the description, from which, without inventive faculty, other drawings can also be obtained for a person skilled in the art.
Fig. 1a is a schematic diagram of a pharmaceutical supply management system based on a blockchain according to an embodiment of the present disclosure.
Fig. 1b is a schematic diagram of a block chain-based drug supply management system according to an embodiment of the present disclosure.
Fig. 2a is a schematic diagram of the drug supply management system provided in example 1.
Fig. 2b is a schematic diagram of the drug supply management system provided in example 2.
Fig. 3a is a schematic diagram of steps of a blockchain-based drug supply management method according to an embodiment of the present disclosure.
FIG. 3b is a second schematic diagram of a block chain-based drug supply management method according to one embodiment of the present disclosure.
Fig. 4 is a schematic structural diagram of an electronic device according to an embodiment of the present disclosure.
Detailed Description
In order that those skilled in the art will better understand the technical solutions in this specification, a clear and complete description of the technical solutions in one or more embodiments of this specification will be provided below with reference to the accompanying drawings in one or more embodiments of this specification, and it is apparent that the one or more embodiments described are only a part of embodiments of this specification, not all embodiments. All other embodiments, which can be made by one or more embodiments of the present disclosure without inventive faculty, are intended to be within the scope of the present disclosure.
Example 1
Referring to fig. 1a, a schematic structural diagram of a drug supply management system based on a blockchain is provided in an embodiment of the present disclosure, where the drug supply management system may at least include: a healthcare facility side 102, a third party logging platform 104, a drug provider 106, and a blockchain network 108; wherein the medical institution side 102, the third party logging platform 104, and the drug provider 106 are each deployed with a block link point module. It should be appreciated that the blockchain node module may specifically include: the information uplink module is used for uploading various information related to the drug supply received or acquired to the blockchain network; and the information verification module is used for comparing and verifying whether the received or collected various plaintext information related to the medicine is consistent with the similar ciphertext information stored on the blockchain network, and returning a verification result. In addition, the block link point module may further include: and the payment module is used for directly uploading the medicine buying payment information of the patient to the blockchain network or uploading the medicine buying payment information of the patient to the blockchain network through a third party payment platform, or selecting to exchange points on the third party payment platform for payment and simultaneously carrying out payment.
The medical institution side 102 encrypts and signs the diagnosis information carrying the medicine information, and then uploads the diagnosis information to the blockchain network 108, and sends the diagnosis information to the third party record platform 104. In the embodiment of the present disclosure, the medical institution side 102 may specifically be a terminal corresponding to a medical institution capable of issuing medicines, such as a hospital, a clinic, and a pharmacy. Each medical institution can have its own internal service network, and is respectively connected with a third party record platform and connected with the blockchain network through a deployed blockchain node module. The diagnostic information may be information related to the patient and the drug supply including drug information, patient condition, medical facility ID, and the like. The medical institution side can package the information into diagnosis information, and the diagnosis information is uploaded to the blockchain network for storage through the information uplink module. It should be appreciated that prior to uploading, the plaintext information, diagnostic information, needs to be hashed and signed with the private key of the medical institution side 102 to verify and authenticate the current drug delivery service.
Optionally, the healthcare facility side 102 may store the diagnostic information in the form of plaintext information in a corresponding database in addition to uploading the cryptographically signed diagnostic information to the blockchain network 108. For example, a local database stored at the medical facility 102, or a cloud database corresponding to the medical facility 102.
The third party record platform 104 compares the received diagnosis information with the diagnosis information stored with the encrypted signature in the blockchain network 108, and stores the diagnosis information in a corresponding database after the comparison and the matching; in order to verify the present drug delivery service, the third party record platform 104 may compare the received plaintext diagnostic information with the ciphertext-form diagnostic information stored in the blockchain network 108 to determine whether the received plaintext diagnostic information is the same diagnostic information, so as to verify the same. If verification is successful, that is, after comparison and matching, the diagnosis information in a plaintext form is stored in a database corresponding to the third party record platform 104, and may specifically be stored in a local database of the third party record platform 104 or be stored in a cloud database corresponding to the third party record platform 104. If the verification fails, the third party logging platform 104 does not store the diagnostic information.
The third party record platform 104 also performs an audit on the current drug supply service, and uploads the audit result and the sales information in the drug information to the blockchain network 108 after encryption signature. In a specific implementation, the third party record platform 104 may perform an audit on the current drug supply service, specifically audit whether the current diagnostic information is wrong, or whether the current diagnostic information is valid, whether the patient has medical insurance, or the like. And then, carrying out hash encryption and signature on the auditing result and the sales information, and uploading the results to a block chain network for storage through an information uplink module.
Alternatively, the third party logging platform 104 may directly store audit information and sales information in the corresponding databases in addition to uploading the audit information and sales information encrypted signatures to the blockchain network. The data may be stored in a local database of the third party recording platform 104, or in a cloud database corresponding to the third party recording platform 104.
When the patient pays for buying a drug, the medical institution 102 triggers the third party record platform 104 to verify the diagnostic information, and after the verification is successful, the payment information, the order information and the drug sales status are uploaded to the blockchain network 108; specifically, when the patient pays for purchasing the medicine at the pharmacy through the payment module, the medical institution side is presented with the medicine purchasing information of the patient at the third party record platform 104, wherein the medicine purchasing information can be sent to the patient by the third party record platform 104 after the verification is successful. The medical institution side verifies the drug information and the patient information in the diagnosis information through the information verification module, and after the verification is successful, the information uplink module uploads the payment information, the order information and the drug sales state to the blockchain network 108.
The medicine provider 106 packages all uplink information corresponding to the medicine supply service as receivables information, and signs the asset corresponding to the medicine purchase; wherein the ownership of the signed asset is attributed to the drug provider 106.
Therefore, the medicine provider can conduct insurance and financing on receivables in the period of medicine sales account through the system, cash flow is increased under the condition that accounts are received immediately but the accounts are not received actually, the utilization rate of funds is improved in a risk controllable mode, and the safety of information flow is guaranteed.
One implementation, as shown with reference to fig. 1b, further includes: a financial service provider 110;
the financial service provider 110 performs a uplink check on the sales status of the medicines supplied and sold by the medicine provider 106, and determines whether to provide a specific asset service to the medicine provider 106.
It should be appreciated that in embodiments of the present description, the particular asset service may be a financing service, or other service that may be performed using the asset.
Specifically, sales and demand of the medicines sold by the medicine suppliers, the condition of refund, etc. can be checked. If sales, demand, etc. are high and the refund is timely, it is determined that financing services can be provided for the drug provider. It should be noted that the judgment can be specifically performed according to the policy conditions of each financial service party.
An achievable scheme is that when the judgment result is yes, the drug supplier changes the ownership of the asset into the financial service side, and a manageable deposit management account is set up at the financial service side; the deposit and management account is used for receiving the refund asset of the medical institution side.
Optionally, after receiving the refund asset, the financial service party reimburses the asset on the blockchain network.
The embodiments of the present specification are described in detail below by way of two examples.
Referring to fig. 2a, a schematic diagram of a drug supply management system is provided for example 1. In the medicine supply management system, comprising: hospitals, drug information management platforms, drug suppliers, and blockchain networks.
When a hospital opens medicines, the hospital information, the patient information and the medicine information are packaged into an information package, the information package is stored on a blockchain network through an information uplink module, the stored information is in the form of hashing plaintext information, the generated hash value is stored on the blockchain, and the hash value has signature information of the hospital to prove that the hospital can certify the medicine sales information.
And then, the hospital stores the clear text information of the prescribed medicines in a database, and transmits the clear text information to a medicine information recording platform through the database.
The medicine information recording platform compares plaintext information provided by a hospital with ciphertext information on a blockchain network through an information verification module, and if verification is successful, the information is stored in a database of the medicine information recording platform. If the verification is unsuccessful, the information is not stored.
After the drug information recording platform successfully checks and stores the data, the information uplink module stores the drug sales information and the audit information on the blockchain in a way of hashing the self audit result and the drug sales information and then stores the hash value on the blockchain.
After the hash value of the medicine sales information is stored, the medicine information recording platform stores plaintext information of medicine sales in a database of an own informatization system.
Further, when a patient purchases a medicine through the payment module at the pharmacy, the medicine purchasing information of the patient at the first medicine information recording platform is displayed to the pharmacy, and the pharmacy verifies the medicine information and the patient information at the medicine information recording platform through the information verification module.
If the pharmacy is successful in verifying the medication information and patient information, the payment information, medication order information, and medication sales status are stored on the blockchain via the information-linking system.
Further, the drug supplier packages the blockchain information binding the user information, the drug circulation information and the payment information into receivables through the on-chain asset management module, and adds ownership to the assets in a signature mode to be displayed on the blockchain as own assets.
Referring to fig. 2b, a schematic diagram of a drug supply management system is provided for example 2. In the medicine supply management system, comprising: hospitals, drug information management platforms, drug suppliers, financial institutions, and blockchain networks.
When a hospital opens medicines, the hospital information, the patient information and the medicine information are packaged into an information package, the information package is stored on a blockchain network through an information uplink module, the stored information is in the form of hashing plaintext information, the generated hash value is stored on the blockchain, and the hash value has signature information of the hospital to prove that the hospital can certify the medicine sales information.
And then, the hospital stores the clear text information of the prescribed medicines in a database, and transmits the clear text information to a medicine information recording platform through the database.
The medicine information recording platform compares plaintext information provided by a hospital with ciphertext information on a blockchain network through an information verification module, and if verification is successful, the information is stored in a database of the medicine information recording platform. If the verification is unsuccessful, the information is not stored.
After the drug information recording platform successfully checks and stores the data, the information uplink module stores the drug sales information and the audit information on the blockchain in a way of hashing the self audit result and the drug sales information and then stores the hash value on the blockchain.
After the hash value of the medicine sales information is stored, the medicine information recording platform stores plaintext information of medicine sales in a database of an own informatization system.
Further, when a patient purchases a medicine through the payment module at the pharmacy, the medicine purchasing information of the patient at the first medicine information recording platform is displayed to the pharmacy, and the pharmacy verifies the medicine information and the patient information at the medicine information recording platform through the information verification module.
If the pharmacy is successful in verifying the medication information and patient information, the payment information, medication order information, and medication sales status are stored on the blockchain via the information-linking system.
Further, the drug supplier packages the blockchain information binding the user information, the drug circulation information and the payment information into receivables through the on-chain asset management module, and adds ownership to the assets in a signature mode to be displayed on the blockchain as own assets.
Thereafter, financial institutions such as banks and insurance companies can review and review the drug sales information through the in-chain assets and decide whether to provide financing services.
If the bank and the insurance company decide to provide financing service, a loan is provided to the drug provider, while the drug provider changes ownership of the in-chain property from the drug provider to the bank or the insurance company, and a three-party deposit account is established at the bank for receiving the return of the hospital.
After the hospital returns to the three-party deposit management account, the bank and the insurance company verify the on-chain assets to obtain interest income.
As can be seen from the above examples 1 and 2, the drug supplier can perform the security and financing on the receivables in the period of selling the drug by using the system, and increase cash flow under the condition that the accounts are received immediately but not actually received, and increase the utilization rate of funds in a risk-controllable manner, so as to ensure the security of information flow.
Example two
Referring to fig. 3a, a schematic step diagram of a drug supply management method based on a blockchain is provided in an embodiment of the present disclosure, where the drug supply management method may be applied in a drug supply management system including a medical institution side, a third party record platform, a drug supplier side, and a blockchain network; wherein the medical institution side, the third party record platform and the medicine provider are respectively provided with a blockchain node module; the method may comprise the steps of:
step 302: the medical institution side encrypts and signs diagnosis information carrying medicine information and then uploads the diagnosis information to a blockchain network, and sends the diagnosis information to the third party record platform;
step 304: the third party record platform compares the received diagnosis information with the diagnosis information stored with the encrypted signature in the blockchain network, and stores the diagnosis information in a corresponding database after comparison and matching;
step 306: the third party record platform carries out auditing on the current medicine supply business, and uploads the auditing result and the sales information encryption signature in the medicine information to a blockchain network;
step 308: when a patient pays for buying a medicine, the medical institution triggers the third party record platform to verify the diagnosis information, and uploads payment information, order information and medicine sales state to a blockchain network after the verification is successful;
step 310: the medicine provider packages all uplink information corresponding to the medicine supply business to form accounts receivable information, and signs the assets corresponding to the medicine purchase; wherein the ownership of the signed asset is attributed to the drug supplier.
Optionally, as an embodiment, referring to fig. 3b, the drug supply management method further includes:
step 312: and the financial service side performs uplink check on the medicine sales status supplied and sold by the medicine supplier and decides whether to provide specific asset service for the medicine supplier.
In a specific implementation manner of the embodiment of the present specification, the method further includes:
when the judgment result is yes, the medicine provider changes the ownership of the asset into the financial service provider, and a manageable deposit and management account is set up at the financial service provider; the deposit and management account is used for receiving the refund asset of the medical institution side.
In yet another specific implementation of an embodiment of the present disclosure, the financial service party reimburses the asset on the blockchain network after receiving the refund asset.
In still another specific implementation manner of the embodiment of the present disclosure, the medical institution side further stores the diagnostic information in a database corresponding to the medical institution side.
In still another specific implementation manner of this embodiment of the present disclosure, the third party record platform further stores the auditing result and the sales information in the drug information in a database corresponding to the third party record platform.
Through the technical scheme, the medicine provider can conduct insurance financing on accounts receivable in the period of medicine sales account through the system, cash flow is increased under the condition that accounts are received immediately but the accounts are not received actually, the utilization rate of funds is improved in a risk controllable mode, and the safety of information flow is guaranteed.
Example III
Fig. 4 is a schematic structural view of an electronic device according to an embodiment of the present specification. Referring to fig. 4, at the hardware level, the electronic device includes a processor, and optionally an internal bus, a network interface, and a memory. The Memory may include a Memory, such as a Random-Access Memory (RAM), and may further include a non-volatile Memory (non-volatile Memory), such as at least 1 disk Memory. Of course, the electronic device may also include hardware required for other services.
The processor, network interface, and memory may be interconnected by an internal bus, which may be an ISA (Industry Standard Architecture ) bus, a PCI (Peripheral Component Interconnect, peripheral component interconnect standard) bus, or EISA (Extended Industry Standard Architecture ) bus, among others. The buses may be classified as address buses, data buses, control buses, etc. For ease of illustration, only one bi-directional arrow is shown in FIG. 4, but not only one bus or type of bus.
And the memory is used for storing programs. In particular, the program may include program code including computer-operating instructions. The memory may include memory and non-volatile storage and provide instructions and data to the processor.
The processor reads the corresponding computer program from the nonvolatile memory into the memory and then runs the computer program, and forms each execution subject device involved in the drug supply management system on a logic level. And the processor is used for executing the program stored in the memory and particularly executing the method steps executed by each execution body in the medicine supply management system.
The method performed by the apparatus disclosed in the embodiments shown in fig. 2a and fig. 2b of the present specification may be applied to a processor or implemented by a processor. The processor may be an integrated circuit chip having signal processing capabilities. In implementation, the steps of the above method may be performed by integrated logic circuits of hardware in a processor or by instructions in the form of software. The processor may be a general-purpose processor, including a central processing unit (Central Processing Unit, CPU), a network processor (Network Processor, NP), etc.; but also digital signal processors (Digital Signal Processor, DSP), application specific integrated circuits (Application Specific Integrated Circuit, ASIC), field programmable gate arrays (Field-Programmable Gate Array, FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components. The methods, steps, and logic blocks disclosed in one or more embodiments of the present description may be implemented or performed. A general purpose processor may be a microprocessor or the processor may be any conventional processor or the like. The steps of a method disclosed in connection with one or more embodiments of the present disclosure may be embodied directly in a hardware decoding processor or in a combination of hardware and software modules in a decoding processor. The software modules may be located in a random access memory, flash memory, read only memory, programmable read only memory, or electrically erasable programmable memory, registers, etc. as well known in the art. The storage medium is located in a memory, and the processor reads the information in the memory and, in combination with its hardware, performs the steps of the above method.
The electronic device may also execute the methods of fig. 2a and fig. 2b, and implement the functions of the embodiments of the corresponding devices shown in fig. 2a and fig. 2b, which are not described herein again.
Of course, in addition to the software implementation, the electronic device of the embodiments of the present disclosure does not exclude other implementations, such as a logic device or a combination of software and hardware, that is, the execution subject of the following processing flow is not limited to each logic unit, but may also be hardware or a logic device.
Through the technical scheme, the medicine provider can conduct insurance financing on accounts receivable in the period of medicine sales account through the system, cash flow is increased under the condition that accounts are received immediately but the accounts are not received actually, the utilization rate of funds is improved in a risk controllable mode, and the safety of information flow is guaranteed.
Example IV
The present description also proposes a computer-readable storage medium storing one or more programs, the one or more programs comprising instructions, which when executed by a portable electronic device comprising a plurality of application programs, enable the portable electronic device to perform the method of the embodiment shown in fig. 2a and 2b, and in particular to perform the method steps involved in the respective execution bodies in a drug supply management system.
Through the technical scheme, the medicine provider can conduct insurance financing on accounts receivable in the period of medicine sales account through the system, cash flow is increased under the condition that accounts are received immediately but the accounts are not received actually, the utilization rate of funds is improved in a risk controllable mode, and the safety of information flow is guaranteed.
In summary, the foregoing description is only a preferred embodiment of the present invention and is not intended to limit the scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present specification should be included in the protection scope of the present specification.
The systems, devices, modules, or units illustrated in one or more of the embodiments described above may be implemented in particular by a computer chip or entity, or by a product having some function. One typical implementation is a computer. In particular, the computer may be, for example, a personal computer, a laptop computer, a cellular telephone, a camera phone, a smart phone, a personal digital assistant, a media player, a navigation device, an email device, a game console, a tablet computer, a wearable device, or a combination of any of these devices.
Computer readable media, including both non-transitory and non-transitory, removable and non-removable media, may implement information storage by any method or technology. The information may be computer readable instructions, data structures, modules of a program, or other data. Examples of storage media for a computer include, but are not limited to, phase change memory (PRAM), static Random Access Memory (SRAM), dynamic Random Access Memory (DRAM), other types of Random Access Memory (RAM), read Only Memory (ROM), electrically Erasable Programmable Read Only Memory (EEPROM), flash memory or other memory technology, compact disc read only memory (CD-ROM), digital Versatile Discs (DVD) or other optical storage, magnetic cassettes, magnetic tape magnetic disk storage or other magnetic storage devices, or any other non-transmission medium, which can be used to store information that can be accessed by a computing device. Computer-readable media, as defined herein, does not include transitory computer-readable media (transmission media), such as modulated data signals and carrier waves.
It should also be noted that the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising one … …" does not exclude the presence of other like elements in a process, method, article or apparatus that comprises the element.
In this specification, each embodiment is described in a progressive manner, and identical and similar parts of each embodiment are all referred to each other, and each embodiment mainly describes differences from other embodiments. In particular, for system embodiments, since they are substantially similar to method embodiments, the description is relatively simple, as relevant to see a section of the description of method embodiments.
The foregoing describes specific embodiments of the present disclosure. Other embodiments are within the scope of the following claims. In some cases, the actions or steps recited in the claims can be performed in a different order than in the embodiments and still achieve desirable results. In addition, the processes depicted in the accompanying figures do not necessarily require the particular order shown, or sequential order, to achieve desirable results. In some embodiments, multitasking and parallel processing are also possible or may be advantageous.
Claims (10)
1. A blockchain-based drug supply management system, comprising: a medical institution side, a third party record platform, a drug supplier, and a blockchain network; wherein the medical institution side, the third party record platform and the medicine provider are respectively provided with a blockchain node module;
the medical institution side encrypts and signs diagnosis information carrying medicine information and then uploads the diagnosis information to a blockchain network, and sends the diagnosis information to the third party record platform;
the third party record platform compares the received diagnosis information with the diagnosis information stored with the encrypted signature in the blockchain network, and stores the diagnosis information in a corresponding database after comparison and matching;
the third party record platform also carries out auditing on the current medicine supply service, and uploads the auditing result and sales information in the medicine information to a blockchain network after encryption signature;
when a patient pays for buying a medicine, the medical institution side triggers the third party record platform to verify the diagnosis information, and uploads payment information, order information and medicine sales state to a blockchain network after the verification is successful;
the medicine provider packages all uplink information corresponding to the medicine supply business to form accounts receivable information and signs the assets corresponding to the medicine purchase; wherein the ownership of the signed asset is attributed to the drug supplier; wherein,
when the patient pays to buy the medicine, the medical institution side triggers the third party record platform to verify the diagnosis information, and uploads the payment information, the order information and the medicine sales state to a blockchain network after the verification is successful, and the method comprises the following steps:
when the patient pays for purchasing the medicine, the medicine purchasing information of the patient on the third party record platform is displayed to the medical institution side, wherein the medicine purchasing information can be sent to the patient after the third party record platform is checked successfully, the medical institution side verifies the medicine information and the patient information in the diagnosis information corresponding to the medicine purchasing information, and uploads the payment information, the order information and the medicine selling state to the blockchain network after the verification is successful.
2. The blockchain-based drug supply management system of claim 1, further comprising: a financial service party;
and the financial service side performs uplink check on the medicine sales status supplied and sold by the medicine supplier and judges whether to provide specific asset service for the medicine supplier.
3. The blockchain-based drug supply management system of claim 2, wherein when the determination is yes, the drug supplier changes ownership of the asset to the financial service side, and establishes a manageable deposit account at the financial service side; the deposit and management account is used for receiving the refund asset of the medical institution side.
4. The blockchain-based drug supply management system of claim 3, wherein the financial service, after receiving the refund asset, reimburses the asset on the blockchain network.
5. The blockchain-based drug supply management system of claim 1, wherein the medical institution side further stores the diagnostic information in its own corresponding database.
6. The blockchain-based drug supply management system of claim 1, wherein the third party record platform further stores the auditing result and sales information in the drug information in a database corresponding to the third party record platform.
7. A medicine supply management method based on a blockchain is applied to a medicine supply management system comprising a medical institution side, a third party recording platform, a medicine supplier and a blockchain network; wherein the medical institution side, the third party record platform and the medicine provider are respectively provided with a blockchain node module; the method comprises the following steps:
the medical institution side encrypts and signs diagnosis information carrying medicine information and then uploads the diagnosis information to a blockchain network, and sends the diagnosis information to the third party record platform;
the third party record platform compares the received diagnosis information with the diagnosis information stored with the encrypted signature in the blockchain network, and stores the diagnosis information in a corresponding database after comparison and matching;
the third party record platform carries out auditing on the current medicine supply business, and uploads the auditing result and the sales information encryption signature in the medicine information to a blockchain network;
when a patient pays for buying a medicine, the medical institution side triggers the third party record platform to verify the diagnosis information, and uploads payment information, order information and medicine sales state to a blockchain network after the verification is successful;
the medicine provider packages all uplink information corresponding to the medicine supply business to form accounts receivable information, and signs the assets corresponding to the medicine purchase; wherein the ownership of the signed asset is attributed to the drug supplier; wherein,
when the patient pays to buy the medicine, the medical institution side triggers the third party record platform to verify the diagnosis information, and uploads the payment information, the order information and the medicine sales state to a blockchain network after the verification is successful, and the method comprises the following steps:
when the patient pays for buying the medicine, the medicine purchasing information of the patient on the third party record platform is displayed to the medical institution side, wherein the medicine purchasing information can be sent to the patient after the third party record platform is checked successfully, the medical institution side verifies the medicine information and the patient information in the diagnosis information, and uploads the payment information, the order information and the medicine sales state to the blockchain network after the verification is successful.
8. The blockchain-based drug supply management method of claim 7, further comprising:
and the financial service side performs uplink check on the medicine sales status supplied and sold by the medicine provider, and judges whether to provide specific asset service for the medicine provider.
9. The blockchain-based drug supply management method of claim 8, wherein when the judgment result is yes, the drug supplier changes ownership of the asset to the financial service side, and establishes a manageable deposit account at the financial service side; the deposit and management account is used for receiving the refund asset of the medical institution side.
10. The blockchain-based drug supply management method of claim 9, wherein the financial service, after receiving the refund asset, reimburses the asset on the blockchain network.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010804367.4A CN111967958B (en) | 2020-08-11 | 2020-08-11 | Drug supply management system and method based on blockchain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010804367.4A CN111967958B (en) | 2020-08-11 | 2020-08-11 | Drug supply management system and method based on blockchain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111967958A CN111967958A (en) | 2020-11-20 |
| CN111967958B true CN111967958B (en) | 2024-03-26 |
Family
ID=73365216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010804367.4A Active CN111967958B (en) | 2020-08-11 | 2020-08-11 | Drug supply management system and method based on blockchain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111967958B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112883028B (en) * | 2021-02-09 | 2023-07-07 | 浙江数秦科技有限公司 | Medical data trusted memory management system based on blockchain |
| CN113539450A (en) * | 2021-04-27 | 2021-10-22 | 安徽省立医院(中国科学技术大学附属第一医院) | Method for purchasing and paying medicine in hospital |
| CN113823391B (en) * | 2021-08-29 | 2023-12-12 | 上海舵衔数字科技中心 | Medicine purchase management system |
| CN113744855A (en) * | 2021-08-29 | 2021-12-03 | 上海舵衔数字科技中心 | Medicine nursing method |
| CN115829621B (en) * | 2022-10-31 | 2024-03-26 | 海南星捷安科技集团股份有限公司 | Medical instrument marketing recommendation method and system |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109065115A (en) * | 2018-07-21 | 2018-12-21 | 丁腊春 | Method of completing the square outside prescription based on block chain technology |
| CN109215770A (en) * | 2018-11-02 | 2019-01-15 | 南京汇智万康科技有限公司 | The modeling applied in intelligent medical treatment big data based on block chain technology |
| CN109461485A (en) * | 2018-09-26 | 2019-03-12 | 深圳市康栖信息技术有限公司 | Prescription outflow takes prescription method and server |
| CN109949019A (en) * | 2018-11-15 | 2019-06-28 | 陕西医链区块链集团有限公司 | A kind of payment system based on medical block chain |
| CN110414204A (en) * | 2019-08-01 | 2019-11-05 | 广东珠江智联信息科技股份有限公司 | A kind of shared flow system of internet hospital electronic prescription |
| CN110519063A (en) * | 2019-09-23 | 2019-11-29 | 重庆华医康道科技有限公司 | A kind of working method that the Medicine prescriptions based on block chain effectively configure |
| CN110826108A (en) * | 2019-10-14 | 2020-02-21 | 边缘智能研究院南京有限公司 | Electronic prescription sharing system based on block chain technology |
| CN111276210A (en) * | 2020-03-06 | 2020-06-12 | 江苏朗拓健康科技有限公司 | Prescription sharing platform system |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190206536A1 (en) * | 2018-01-01 | 2019-07-04 | Brian Hausman | System and method for prescription monitoring and drug dispensation utilizing a distributed ledger |
-
2020
- 2020-08-11 CN CN202010804367.4A patent/CN111967958B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109065115A (en) * | 2018-07-21 | 2018-12-21 | 丁腊春 | Method of completing the square outside prescription based on block chain technology |
| CN109461485A (en) * | 2018-09-26 | 2019-03-12 | 深圳市康栖信息技术有限公司 | Prescription outflow takes prescription method and server |
| CN109215770A (en) * | 2018-11-02 | 2019-01-15 | 南京汇智万康科技有限公司 | The modeling applied in intelligent medical treatment big data based on block chain technology |
| CN109949019A (en) * | 2018-11-15 | 2019-06-28 | 陕西医链区块链集团有限公司 | A kind of payment system based on medical block chain |
| CN110414204A (en) * | 2019-08-01 | 2019-11-05 | 广东珠江智联信息科技股份有限公司 | A kind of shared flow system of internet hospital electronic prescription |
| CN110519063A (en) * | 2019-09-23 | 2019-11-29 | 重庆华医康道科技有限公司 | A kind of working method that the Medicine prescriptions based on block chain effectively configure |
| CN110826108A (en) * | 2019-10-14 | 2020-02-21 | 边缘智能研究院南京有限公司 | Electronic prescription sharing system based on block chain technology |
| CN111276210A (en) * | 2020-03-06 | 2020-06-12 | 江苏朗拓健康科技有限公司 | Prescription sharing platform system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111967958A (en) | 2020-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111967958B (en) | Drug supply management system and method based on blockchain | |
| US10965673B2 (en) | User ID codes for online verification | |
| US20220045845A1 (en) | Autonomous exchange via entrusted ledger token and transaction management | |
| US20180285971A1 (en) | Management of consumer debt collection using a blockchain and machine learning | |
| BR112019010235A2 (en) | system and method for reducing fraud in commercial insurance and financing | |
| WO2018049423A1 (en) | Multiparty reconciliation systems and methods | |
| US20210192541A1 (en) | Account owner funding of know your customer and accredited investor verification renewal and monitoring charges through coin payment | |
| US20180204216A1 (en) | Transaction settlement systems and methods | |
| EP3961457A1 (en) | Data check methods, apparatuses, and devices | |
| WO2020108151A1 (en) | Payment method and apparatus, and device | |
| US11475453B2 (en) | System and techniques for utilizing a smart contracts library | |
| US11669812B2 (en) | Contingent payments for virtual currencies | |
| CN112561407B (en) | Asset management method, system and device based on block chain | |
| CN111461852A (en) | Data processing method and device based on block chain and readable storage medium | |
| CN112488725B (en) | Private authorized transfer method, device and storage medium | |
| CN110992162A (en) | Resource processing method, device, equipment and system | |
| KR20210047311A (en) | Verify that the transaction address is whitelisted prior to allowing the transfer of the self-regulatory token to the transaction address, which requires a whitelisted transaction address to withdraw the self-regulatory token. | |
| CN114358944A (en) | Block chain-based trade track voucher generation method and device | |
| CN114066451A (en) | Method and system for managing fund transaction and electronic equipment | |
| US11574299B2 (en) | Providing identification information during an interaction with an interactive computing environment | |
| CN112561679A (en) | Credit investigation system, credit investigation method, electronic device and storage medium | |
| CN112990811A (en) | Block chain-based warehouse receipt processing method and warehouse receipt processing system | |
| WO2018170469A1 (en) | Transaction settlement systems and methods | |
| CN116468562A (en) | Insurance claim settlement method and apparatus based on block chain | |
| CN113627918A (en) | Settlement payment method and device based on distributed digital identity DID |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |